Add BrightSurf on Google Email

“Unlocking” sarcopenic obesity: A review in portal hypertension & cirrhosis provides clarity on key aspects of disease impact and treatment

Researchers from Tianjin Medical University General Hospital review sarcopenic obesity's impact on liver disease, including nonalcoholic fatty liver disease and cirrhosis. The study aims to clarify the pathogenesis of sarcopenic obesity and identify potential therapeutic avenues.

SourceCactus Communications·JournalPortal Hypertension & Cirrhosis·TypeLiterature review·DateJul 6, 2022

Prenatal exposure to chemicals in consumer and industrial products is associated with rising liver disease in children

A comprehensive study found that prenatal exposure to endocrine-disrupting chemicals is associated with non-alcoholic fatty liver disease in children. The researchers measured 45 chemicals in pregnant women and found elevated levels of biomarkers indicating risk for liver disease in children who were more highly exposed.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJAMA Network Open·DateJul 6, 2022
Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

New method improves diagnosis of fatty liver disease

A new method using ethyl glucuronide in hair and urine has improved the diagnosis of fatty liver disease, revealing a high rate of harmful alcohol consumption in patients with presumed non-alcoholic fatty liver disease. The study found that about 30% of patients were at risk of alcohol-related liver damage.

SourceMedical University of Vienna·JournalJournal of Hepatology·DateJul 5, 2022

New genetic associations in pediatric NAFLD affect both risk and severity

Researchers found multiple gene variants contributing to pediatric NAFLD risk and disease severity, including novel SNPs associated with liver fibrosis. These genetic associations may guide future therapeutics for pediatric NAFLD, a chronic childhood disease linked to increased cardiovascular risk and mortality.

SourceUniversity of California - San Diego·JournalHepatology·DateJun 27, 2022

New blood biomarker identified for status of fatty liver disease

A MedUni Vienna study team has identified a specific subtype of macrophages as a protective function against fibrosis in non-alcoholic fatty liver disease. TREM2-positive macrophages have been shown to prevent fat accumulation, inflammatory processes and progression to liver fibrosis.

SourceMedical University of Vienna·JournalJournal of Hepatology·DateJun 21, 2022
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Pediatric liver disease increases risk of developing type 2 diabetes

A new study has found that nonalcoholic fatty liver disease (NAFLD) in children significantly increases the risk of developing type 2 diabetes. The study, published in Clinical Gastroenterology and Hepatology, revealed that among 892 children with NAFLD, 6.6% developed type 2 diabetes, with the incidence rate rising by 3% annually.

SourceUniversity of California - San Diego·JournalClinical Gastroenterology and Hepatology·DateJun 13, 2022

Immune cells in the liver regulate body temperature

Scientists at CNIC discovered a complex network between liver tissue connections that allows the liver to regulate body temperature. The secretion of IL-12 by liver-infiltrating macrophages blocks FGF21 production, reducing heat generation by brown fat in mice.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalHepatology·TypeExperimental study·DateJun 13, 2022

People who consume too much high fructose corn syrup could be at risk for NAFLD

Research suggests that high fructose consumption is associated with a higher chance of developing non-alcoholic fatty liver disease (NAFLD), especially among Mexican Americans and non-Hispanic Blacks. The study analyzed data from over 3,200 participants and found that those consuming the highest amount of fructose were at greatest risk.

SourceThe Endocrine Society·DateJun 12, 2022
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

The gut microbiome as a health compass

Researchers developed a machine learning model to predict NAFLD development based on gut microbiome data, showing 90% of subjects who developed the disease had subtle differences in their samples. The model combines easily measurable information from blood and microbiome data with high accuracy.

SourceLeibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute -·JournalScience Translational Medicine·TypeComputational simulation/modeling·DateJun 9, 2022

Causes of liver cancer are changing around the world: Some up, some down

The primary causes of liver cancer are changing globally, with advances in hepatitis B vaccinations and antiviral therapies reducing HBV-associated liver cancer. However, alcohol consumption and obesity are rising, leading to increased liver cancer deaths. The incidence of NASH is projected to increase further due to rising obesity rates.

SourceUniversity of California - San Diego·JournalCell Metabolism·DateJun 6, 2022

More cardiovascular disease found in lean people with non-alcoholic fatty liver disease than in those who are overweight with the same condition

Researchers discovered that lean individuals with non-alcoholic fatty liver disease (NAFLD) are at a higher risk of developing cardiovascular diseases compared to those who are overweight or obese. Despite lower rates of other health conditions, lean patients with NAFLD exhibited increased prevalence of cardiovascular disease.

SourceDigestive Disease Week·DateMay 24, 2022
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

New CMJ Review explores the metabolic dysfunction associated fatty liver disease

A new review highlights the risks of fatty liver disease caused by metabolic dysfunction, characterized by fat accumulation in liver cells and oxidative stress. The progression of the disease can lead to inflammation, fibrosis, and cirrhosis with a high risk of hepatocellular carcinoma.

SourceCactus Communications·JournalChinese Medical Journal·TypeLiterature review·DateMay 19, 2022

More cardiovascular disease found in lean people with non-alcoholic fatty liver disease than in those who are overweight with the same condition

A new study found that lean individuals with non-alcoholic fatty liver disease (NAFLD) have a higher prevalence of cardiovascular disease compared to those who are overweight or obese. Despite having lower risks for other metabolic and cardiovascular conditions, lean patients with NAFLD were more likely to develop cardiovascular disease.

SourceAmerican Gastroenterological Association·DateMay 13, 2022

Seven out of ten patients with non-alcoholic fatty liver disease feel stigmatized

A study led by the University of Barcelona found that 69% of patients with non-alcoholic fatty liver disease perceive stigmatization in their daily lives, affecting stereotypes, discrimination, shame, and social isolation. The perceived stigma is associated with impaired quality of life and can lead to human and social rights issues.

SourceUniversity of Barcelona·JournalPLOS ONE·TypeObservational study·DateMay 12, 2022

Scientists study links between obesity, age and body chemistry

Researchers investigate how enzymes regulate metabolism, weight gain, and liver disease, revealing diet's significant role in obesity and altered lipid profiles. The study also shows that age affects metabolic processes, leading to weight gain, increased fat storage, and unhealthy liver changes.

SourceClemson University·JournalJournal of Lipids·TypeExperimental study·DateMay 11, 2022
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

Study sheds light on the benefits of exercise in fatty liver disease

A new study published in Scientific Reports reveals that regular high-intensity interval training exercise can significantly decrease fasting glucose levels and waist circumference, while improving oxygen consumption rates in patients with non-alcoholic fatty liver disease. Exercise also modifies amino acid metabolism in adipose tissue...

SourceUniversity of Eastern Finland·JournalScientific Reports·DateMay 3, 2022

Synthetic “forever chemicals” known as PFAS linked to liver damage

A new study systematically reviews data on PFAS exposure and liver damage, linking three commonly detected PFAS to elevated levels of a liver enzyme, ALT. The research suggests a potential link between PFAS and non-alcoholic fatty liver disease (NAFLD), a growing public health crisis affecting 25% of adults worldwide.

SourceKeck School of Medicine of USC·JournalEnvironmental Health Perspectives·TypeMeta-analysis·DateApr 27, 2022

Kisspeptin: A new drug to treat liver disease?

A modified version of the hormone kisspeptin has been shown to protect against the development of fat in the liver and reduce inflammation and fibrosis in a mouse model. This could potentially favorably impact the health and lives of millions of patients around the globe.

SourceRutgers University·JournalJournal of Clinical Investigation·DateApr 7, 2022
Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

Boosting liver mRNAs curbs appetite, body weight in obese mice

A breakthrough discovery has identified a novel approach to tackle metabolic diseases by inhibiting a liver enzyme that regulates appetite and energy expenditure. The treatment, which stabilizes key proteins in the blood, resulted in significant weight loss and improved insulin sensitivity in obese mice.

SourceUniversity of Texas Health Science Center at San Antonio·JournalCell Metabolism·TypeExperimental study·DateApr 5, 2022

Mineral supplement could stop fatty liver disease progression

A preclinical study found that mice fed a high-fat diet and given the mineral supplement Aquamin did not develop liver cancer, unlike those without the supplement. The researchers observed a dramatic reduction in late-stage consequences of non-alcoholic steatohepatitis (NASH) in animals receiving the supplement.

SourceExperimental Biology·DateApr 3, 2022
GQ GMC-500Plus Geiger Counter

GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.

TGen-Temple review suggests even normal weight individuals are susceptible to severe fatty liver disease

Even normal weight individuals are susceptible to severe fatty liver disease due to various risk factors including diet, genetics, and ethnicity. Nonalcoholic fatty liver disease can progress to nonalcoholic steatohepatitis and cirrhosis if left undiagnosed or untreated.

SourceThe Translational Genomics Research Institute·JournalDiabetology & Metabolic Syndrome·TypeLiterature review·DateMar 24, 2022

Pusan National University scientists discover why women are more resistant to nonalcoholic fatty liver disease than men

Researchers found that female mice produce more of the FPR2 protein, which helps prevent NAFLD, and that estrogen mediates its production. This discovery highlights the need for sex-balanced animal experiments and could lead to novel treatments and gender-based therapies for NASH

SourcePusan National University·JournalNature Communications·TypeExperimental study·DateMar 17, 2022

A new study relates liquid fructose intake to fatty liver disease

A new study reveals that liquid fructose intake, even in high-fat diets, can accelerate liver fat accumulation and hypertriglyceridemia. The study found that fructose induces an increase in the synthesis of fatty acids in the liver and inhibits lipid oxidation, leading to the emergence of non-alcoholic fatty liver disease (NAFLD).

SourceUniversity of Barcelona·JournalMolecular Nutrition & Food Research·TypeExperimental study·DateMar 4, 2022

Women with irregular periods may be at risk for liver disease

Researchers found that long or irregular menstrual cycles in young women are associated with an increased risk of nonalcoholic fatty liver disease (NAFLD). NAFLD is a chronic condition where excess fat builds up in the liver, increasing the risk of death. Lifestyle changes can help reduce the risk of NAFLD in these women.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateMar 3, 2022
Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

Diseased male livers undergo sex-change

Research by the University of Queensland found that male livers with hepatic diseases undergo a sex change as part of a self-protective mechanism. The study suggests that this transformation may be driven by the female hormone oestrogen, which helps to slow down disease progression.

SourceUniversity of Queensland·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 21, 2022

Hospital admission with liver cirrhosis: highest mortality rate of all chronic diseases

A nationwide study in Germany found that liver cirrhosis has the highest mortality rate among chronic diseases, with 0.94% of hospital admissions affected. The study also showed a decline in mortality rates due to improvements in Hepatitis C treatment, but an increase in non-alcoholic fatty liver disease cases.

SourceGoethe University Frankfurt·JournalThe Lancet Regional Health - Europe·TypeObservational study·DateFeb 11, 2022

Understudied lncRNAs could help enable early detection of potentially deadly liver disease

A comprehensive review highlights recently discovered associations between lncRNAs and specific diseases, including fatty liver disease and liver cancer. The study suggests that a diverse group of molecules known as long noncoding RNAs could emerge as biomarkers for liver disease.

SourceThe Translational Genomics Research Institute·JournalAnnual Review of Pathology Mechanisms of Disease·TypeLiterature review·DateFeb 8, 2022
Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.

Development of fatty liver disease under a healthy diet

Researchers found that alterations in the RNF43 and ZNRF3 genes lead to an accumulation of lipids and inflammation in the liver, increasing the risk of developing non-alcoholic steatohepatitis (NASH) and fatty liver disease. These genetic changes also affect liver cell proliferation, contributing to the progression of liver diseases.

SourceMax Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG)·JournalNature Communications·TypeExperimental study·DateJan 17, 2022

New potential target molecule for fatty liver disease therapy

A study by Kanazawa University researchers found that the chemokine CCL3 plays a significant role in inducing inflammation as nonalcoholic fatty liver disease develops. The presence of CCL3 increased liver macrophage accumulation, leading to liver inflammation and scarring.

SourceKanazawa University·JournalMetabolism·DateDec 26, 2021

How regular exercise can protect against fatty liver associated diseases

Exercise modifies the adaptation of the liver to increased energy intake, regulating enzymes for glucose and fructose degradation. Regular physical activity also improves glucose control and reduces fat storage in the liver, offering a comprehensive insight into molecular adaptations to high-energy diets.

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalMolecular Metabolism·DateDec 20, 2021
Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

Lack of access to affordable, nutritious food puts those with chronic liver disease at a higher risk of death

A new study by Keck Medicine of USC found that food insecurity increases the risk of death among patients with nonalcoholic fatty liver disease and advanced liver disease. The study, which analyzed data from over 34,000 individuals, suggests that eradicating food insecurity could eliminate up to 7% of nonalcoholic fatty liver disease d...

SourceUniversity of Southern California - Health Sciences·JournalClinical Gastroenterology and Hepatology·TypeData/statistical analysis·DateDec 16, 2021

Novel vaccine may yield affordable solution to lipid disorders

Scientists at Kumamoto University have developed a novel peptide vaccine that improves obesity-related dyslipidemia and may be cost-effective. The vaccine targets angiopoietin-like protein 3 (ANGPTL3) and has been shown to reduce dyslipidemia in mice, producing antibodies that last for six months.

SourceKumamoto University·JournalCell Reports Medicine·TypeExperimental study·DateDec 13, 2021

New PET imaging-based tool detects liver inflammation from fatty liver disease

A team of researchers at UC Davis Health has developed a novel PET imaging-based tool to detect liver inflammation in non-alcoholic fatty liver disease. The tool uses dynamic PET imaging and mathematical modeling to measure glucose transport from blood to liver tissue, allowing clinicians to quantify liver inflammation.

SourceUniversity of California - Davis Health·JournalClinical Gastroenterology and Hepatology·DateNov 30, 2021

Telehealth-delivered diet and exercise programs led to significant improvements in knee osteoarthritis symptoms and quality of life

Researchers found that video-based, telehealth-delivered exercise and weight loss programs improved pain and function in people with knee osteoarthritis and overweight or obesity. The intervention with dietary component led to substantial weight loss and additional benefits.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateNov 29, 2021
Nikon Monarch 5 8x42 Binoculars

Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.

Promising discovery: D-glyceric acid activates cellular mitochondria and reduces low-grade inflammation in aging humans

A study found that D-glyceric acid treatment improved metabolism, blood parameters, and reduced low-grade inflammation in healthy volunteers aged 50-60 years. The compound's activation of mitochondrial metabolism may help interrupt the spiral of persistent systemic inflammation and improve liver function.

SourceUniversity of Jyväskylä - Jyväskylän yliopisto·JournalFrontiers in Aging·DateNov 15, 2021

Postmenopausal women may benefit from estrogen compound research

Researchers have identified a novel estrogen compound that provides benefits similar to hormone replacement therapy but without the risk factors associated with it. The compound has been shown to reduce excess lipid deposition in the liver and prevent the progression of fibrosis, which can lead to liver failure and metabolic problems.

SourceUniversity of Illinois College of Agricultural, Consumer and Environmental Sciences·JournalNutrients·TypeExperimental study·DateOct 28, 2021
Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

International experts develop Clinical Care Pathway in response to NASH epidemic

A multidisciplinary taskforce developed a Clinical Care Pathway for NAFLD/NASH, outlining practical guidance from screening to patient care management. The pathway aims to provide efficient, safe, and value-based care for patients with NAFLD and NASH, highlighting the importance of early interventions and shared decision-making.

SourceAmerican Gastroenterological Association·JournalGastroenterology·DateOct 1, 2021
Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

DNA modifications could be used to determine the progression of severe liver disease

Researchers found that DNA methylation patterns at specific genomic sites correlated with levels of fibrosis in non-alcoholic fatty liver disease (NAFLD). The study suggests that these patterns could be used to diagnose the severity of this condition, potentially leading to earlier treatment and improved outcomes.

SourceThe Translational Genomics Research Institute·JournalClinical Epigenetics·DateSep 20, 2021

Hypertension and fatty liver don’t add up in death risk

A 34-year follow-up study found that the coexistence of hypertension and fatty liver disease did not exceed their separate effects on mortality. The study suggests a negative interaction between the two conditions on cardiovascular death in non-diabetic men.

SourceUniversity of Eastern Finland·JournalScandinavian Journal of Gastroenterology·DateSep 8, 2021

Benefits of time-restricted eating depend on age and sex

A new study by Salk scientists found that time-restricted eating (TRE) confers multiple health benefits, including reduced risk of type 2 diabetes, fatty liver disease, and sepsis, regardless of age and sex. TRE may also protect against infectious diseases like COVID-19 and improve insulin resistance.

SourceSalk Institute·JournalCell Reports·TypeExperimental study·DateAug 17, 2021
Fluke 87V Industrial Digital Multimeter

Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.

Scientists discover ‘bulkheads’ between liver cells

Researchers at Skoltech have discovered structures called apical bulkheads in liver cells that are responsible for the narrow shape of bile canaliculi. The discovery reveals a key role for the Rab35 protein in regulating hepatocyte lumina formation and suggests potential avenues for medical applications in fatty liver disease and fibrosis

SourceSkolkovo Institute of Science and Technology (Skoltech)·JournalJournal of Cell Biology·TypeExperimental study·DateAug 3, 2021
Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.